Vaccines safe for pregnant women with HIV but show reduced immune response

A meta-analysis in eClinicalMedicine finds vaccines are safe for pregnant women living with HIV, showing reduced immunogenicity compared to those without HIV but no increase in adverse events, highlighting the need for their inclusion in vaccine trials.

Enlaza Therapeutics secures $100m in Series A funding

Enlaza’s platform is designed to produce therapeutic warheads that can covalently attach to drug targets. Credit: Mongkolchon Akesin / Shutterstock.com. Enlaza Therapeutics has raised $100m

May 1, 2024

Making Money in the Psychedelics Industry Will be Harder than Cannabis

Anyone familiar with the cannabis industry knows how difficult it is to make money. Things are going to be even worse for people in the

June 30, 2023

Novel antibiotic-infused hydrogel kills bacteria and promotes cell growth

Hydrogels are popular for use in skin ailments and tissue engineering. These polymer-based biocompatible materials are useful for their abilities to retain water, deliver drugs

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.